Sharon Rosenzweig-Lipson, AgeneBio VP of Research and Development, Presents at the 9th Annual Neurodegeneration Drug Development Summit

Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.

« back to Press Releases

February 25, 2021

Sharon Rosenzweig-Lipson, AgeneBio VP of Research and Development, Presents at the 9th Annual Neurodegeneration Drug Development Summit

Read More

bg-ad-amnestic-mild-cognitive-impairment

Email Alerts

Stay up to date on the latest AgeneBio news.

Register Now